Does anti-VEGF bevacizumab improve survival in experimental sepsis?
- PMID: 28676101
- PMCID: PMC5497351
- DOI: 10.1186/s13054-017-1734-x
Does anti-VEGF bevacizumab improve survival in experimental sepsis?
Figures
Comment on
-
Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis.Crit Care. 2013 May 27;17(3):R97. doi: 10.1186/cc12742. Crit Care. 2013. PMID: 23710641 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
